2008
DOI: 10.1212/01.wnl.0000324625.00404.15
|View full text |Cite
|
Sign up to set email alerts
|

Second consensus statement on the diagnosis of multiple system atrophy

Abstract: These new criteria have simplified the previous criteria, have incorporated current knowledge, and are expected to enhance future assessments of the disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

30
2,511
2
37

Year Published

2009
2009
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 2,732 publications
(2,580 citation statements)
references
References 53 publications
30
2,511
2
37
Order By: Relevance
“…A diagnosis of PD was made based on the UK PD Society Brain Bank clinical diagnostic criteria (Hughes, Daniel, Kilford, & Lees, 1992). MSA and PSP were diagnosed according to the second consensus statement on the diagnosis of MSA (Gilman et al., 2008) and the diagnostic criteria of the National Institute of Neurological Disorders and Stroke and the Society for PSP (Litvan et al., 1996), respectively. Disease severity was rated using Hoehn and Yahr (HY) staging (Hoehn & Yahr, 1967).…”
Section: Methodsmentioning
confidence: 99%
“…A diagnosis of PD was made based on the UK PD Society Brain Bank clinical diagnostic criteria (Hughes, Daniel, Kilford, & Lees, 1992). MSA and PSP were diagnosed according to the second consensus statement on the diagnosis of MSA (Gilman et al., 2008) and the diagnostic criteria of the National Institute of Neurological Disorders and Stroke and the Society for PSP (Litvan et al., 1996), respectively. Disease severity was rated using Hoehn and Yahr (HY) staging (Hoehn & Yahr, 1967).…”
Section: Methodsmentioning
confidence: 99%
“…Twenty-one consecutive patients with a clinical diagnosis of PD, defined according to the United Kingdom PD Brain criteria 11 , 11 consecutive patients with MSA-c, eight patients with MSA-p, according to MSA consensus 3 , and 20 patients with clinical criteria for PSP 2 were examined. All patients were clinically evaluated by a neurologist and submitted to brain MRI.…”
Section: Methodsmentioning
confidence: 99%
“…Other characteristics include fast rate of disease progression and poor response to levodopa 1,2 . Multiple system atrophy (MSA) is usually associated with fast rate of disease progression, autonomic dysfunction, cerebellar signs and upper motor neuron signs 3 . In MSA cases, patients have been classified as MSA-c or MSA-p depending on the predominance of cerebellar ataxia or parkinsonian features, with dysautonomia being a constant feature in both subtypes 4 .…”
mentioning
confidence: 99%
“…The vast majority of patients have been evaluated at least once by trained movement disorders specialists and the following data has been obtained: gender, age at disease onset, disease duration at the time of SPECT, body side predominance and final clinical diagnosis. Regarding degenerative parkinsonian syndromes, we used the UK Parkinson's Disease Study Brain Bank criteria for PD [15], the second consensus statement for the diagnosis of MSA [16], the National Institute of Neurological Disorders Society (NINDS) clinical research criteria for PSP [17] and the criteria for the diagnosis of CBD proposed by Armstrong et al [18]. Patients were classified as having a non-degenerative parkinsonian syndrome or tremor, whenever they fulfilled the criteria for essential tremor [19], dystonic tremor [20], psychogenic parkinsonism [21] or drug-induced parkinsonism as described in Ref.…”
Section: Patientsmentioning
confidence: 99%